| Date | Time | Local Time | Room | Session | Role | Topic |
|---|---|---|---|---|---|---|
| 2020-10-20 | 11:22-11:37 | 2020-10-20,11:22-11:37 | Comprehensive Channel 2 |
Highlights of Hypertension in the Elderly |
Speaker | Management Strategy for the Elderly Patients with Hypertension |
| 2020-10-20 | 14:00-14:15 | 2020-10-20,14:00-14:15 | Hypertension Channel |
Hypertension and Vascular Function |
Speaker | Role of Inflammation in Vascular Function in Hypertension |
| 2020-10-20 | 16:00-16:15 | 2020-10-20,16:00-16:15 | Heart Failure and Cardiomyopathy Channel |
The Newest Development in SGLT2 Inhibitor and Heart Failure |
Speaker | Why the Treatment of Heart Failure Receives Global Attention? |
| 2020-10-21 | 20:20-20:35 | 2020-10-21,20:20-20:35 | Hypertension Channel |
Hypertension in the Elderly |
Speaker | Management of Postural Blood Pressure Changes in the Elderly |
| 2020-10-23 | 17:30-17:45 | 2020-10-23,17:30-17:45 | Clinical Coronary Artery Disease Channel |
Glycolipid Metabolism and Management of ASCVD 【Metabolic Disease and Cardiovascular Disease Forum】 |
Speaker | Should Metformin Be Used as the First-line Drug for Primary Prevention of ASCVD in Diabetes Mellitus? |